What is the recommended tapering protocol for steroids in an infant with infantile spasms (IS) who is currently on prednisolone (corticosteroid) treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroid Tapering Protocol for Infantile Spasms

After achieving spasm cessation with high-dose prednisolone (8 mg/kg/day, maximum 60 mg/day) for 2 weeks, taper the dose over 2 weeks by reducing it gradually, then discontinue. 1, 2

Initial Treatment Duration

  • Administer prednisolone at 8 mg/kg/day (maximum 60 mg/day) divided into three daily doses for 14 days 1, 2
  • Confirm response with video-EEG showing resolution of both epileptic spasms and hypsarrhythmia on day 14 1, 2

Tapering Schedule for Responders

The taper should occur over 14 days following the initial 2-week treatment course. 1, 2

  • Begin tapering only after confirming complete response (absence of spasms and hypsarrhythmia on video-EEG) 1, 2
  • The specific taper schedule involves gradual dose reduction over 2 weeks, though the exact daily decrements are not rigidly specified in the protocols 1, 2
  • One case report used a 5-week taper after 2 weeks of full-dose therapy 3

Management of Non-Responders

If no response after 14 days of prednisolone, immediately transition to ACTH without tapering. 1, 2

  • Switch to natural ACTH at 150 U/m²/day divided in two daily doses for 14 days 1
  • This sequential approach yields cumulative response rates of 84% in treatment-naive patients 1
  • Among prednisolone non-responders, 33-40% will respond to subsequent ACTH therapy 1, 2

Critical Monitoring Points

Relapse risk is substantial even after initial response, occurring in 12-50% of cases between 2-9 months. 1, 2

  • Monitor closely for relapse during the 28 days following taper completion 1
  • Prednisolone responders have lower relapse rates (12%) compared to ACTH responders (50%) 2
  • Extended follow-up is essential as late relapses can occur up to 9 months post-treatment 2

Important Caveats

Treatment-naive patients have significantly better outcomes (84% response) compared to those with prior hormonal therapy exposure (51% response). 1

  • The 8 mg/kg/day dose is substantially higher than traditional prednisolone dosing and demonstrates superior efficacy compared to lower doses used in earlier studies 2
  • Adverse effects are less frequent with prednisolone (53%) compared to ACTH (80%) 4
  • Cost considerations strongly favor prednisolone ($200) over ACTH (approximately $70,000) 4

Do not use abrupt discontinuation after long-term therapy; gradual withdrawal is essential to prevent adrenal insufficiency. 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.